EDEN M MILLER
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine / Obesity Medicine
- Where
- BEND, OR
- NPI
- 1114997988
- Received
- $1,654,967 in 2,946 records, 2019 to 2025
- As principal investigator
- $45,547 of research payments to others in 47 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 583 | $309,454 |
| 2024 | General payment | 411 | $249,420 |
| 2023 | General payment | 381 | $224,748 |
| 2022 | General payment | 368 | $254,436 |
| 2021 | General payment | 308 | $186,235 |
| 2020 | General payment | 364 | $219,701 |
| 2019 | General payment | 531 | $210,970 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 872 | $1,093,923 |
| Consulting Fee | 129 | $234,501 |
| Travel and Lodging | 811 | $153,424 |
| Compensation for serving as faculty or as a speaker for a medical education program | 76 | $91,369 |
| Food and Beverage | 1,040 | $42,167 |
| Honoraria | 6 | $21,535 |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing educat | 5 | $13,800 |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing | 4 | $4,225 |
| Education | 3 | $19 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Corcept Therapeutics | $18 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-12-19 | Abbott Laboratories | $1,125 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $1,125 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $311 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Bayer Healthcare Pharmaceuticals Inc. | $266 | Travel and Lodging | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-12-19 | Abbott Laboratories | $225 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $225 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $80 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $74 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Bayer Healthcare Pharmaceuticals Inc. | $49 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-12-19 | Abbott Laboratories | $36 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-18 | Insulet Corporation | $3,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-18 | Insulet Corporation | $110 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-18 | Insulet Corporation | $48 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-18 | Insulet Corporation | $32 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-18 | Insulet Corporation | $29 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-18 | Insulet Corporation | $6 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-16 | Tandem Diabetes Care, Inc. | $16 | Food and Beverage | In-kind items and services | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-12-13 | VERTEX PHARMACEUTICALS INCORPORATED | $44 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-12 | Insulet Corporation | $4,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-12 | Bayer Healthcare Pharmaceuticals Inc. | $2,698 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-12-12 | Abbott Laboratories | $1,350 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-12 | Abbott Laboratories | $1,125 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-12 | Insulet Corporation | $1,097 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-12 | Abbott Laboratories | $562 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-12 | Abbott Laboratories | $225 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-12 | Abbott Laboratories | $144 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-12 | Abbott Laboratories | $48 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-12 | Abbott Laboratories | $32 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-12 | Abbott Laboratories | $12 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-10 | Novo Nordisk Inc | $1,162 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-12-08 | RECORDATI_RARE_DISEASES_INC. | $20 | Food and Beverage | In-kind items and services | ISTURISA Drug, ENDOCRINE AGENT | 2025 | |
| 2025-12-05 | Abbott Laboratories | $1,125 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-05 | Abbott Laboratories | $506 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-05 | Abbott Laboratories | $87 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-05 | Abbott Laboratories | $60 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-05 | Abbott Laboratories | $39 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-05 | Abbott Laboratories | $32 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-04 | Insulet Corporation | $878 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-04 | Insulet Corporation | $48 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-04 | Insulet Corporation | $48 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-04 | Insulet Corporation | $32 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-04 | Insulet Corporation | $17 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-04 | Insulet Corporation | $6 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-03 | Insulet Corporation | $196 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-03 | Insulet Corporation | $150 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-02 | Abbott Laboratories | $546 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-02 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-21 | Abbott Laboratories | $2,025 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-21 | Novo Nordisk Inc | $1,162 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-21 | Abbott Laboratories | $787 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-21 | Abbott Laboratories | $450 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-21 | Abbott Laboratories | $140 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-21 | Abbott Laboratories | $94 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-21 | Abbott Laboratories | $90 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-21 | Abbott Laboratories | $40 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-21 | Abbott Laboratories | $32 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-20 | Novo Nordisk Inc | $1,604 | Consulting Fee | Cash or cash equivalent | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-11-20 | Insulet Corporation | $1,237 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-11-20 | Insulet Corporation | $20 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-11-20 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-19 | Novo Nordisk Inc | $1,069 | Consulting Fee | Cash or cash equivalent | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-11-17 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-14 | Novo Nordisk Inc | $1,604 | Consulting Fee | Cash or cash equivalent | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-11-13 | Insulet Corporation | $878 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-11-13 | Corcept Therapeutics | $5 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-11-12 | Corcept Therapeutics | $337 | Travel and Lodging | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-11-12 | Corcept Therapeutics | $184 | Travel and Lodging | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-11-12 | Insulet Corporation | $144 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-11-12 | Insulet Corporation | $55 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-11-12 | Corcept Therapeutics | $52 | Food and Beverage | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-11-11 | Abbott Laboratories | $236 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-11 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-10 | Xeris Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | RECORLEV Drug, Adrenal steroidogenesis inhibitor | 2025 | |
| 2025-11-09 | Abbott Laboratories | $23 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-06 | Insulet Corporation | $1,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-11-06 | Bayer Healthcare Pharmaceuticals Inc. | $190 | Travel and Lodging | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-11-06 | Xeris Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | RECORLEV Drug, Adrenal steroidogenesis inhibitor | 2025 | |
| 2025-11-06 | Madrigal Pharmaceuticals | $19 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-11-05 | Novo Nordisk Inc | $3,836 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-05 | Novo Nordisk Inc | $291 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-05 | Novo Nordisk Inc | $110 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-05 | Bayer Healthcare Pharmaceuticals Inc. | $70 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-11-04 | Abbott Laboratories | $111 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-04 | Abbott Laboratories | $111 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-04 | Insulet Corporation | $60 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-11-03 | Corcept Therapeutics | $14 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-10-30 | Insulet Corporation | $55 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-29 | Eli Lilly and Company | $3,025 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-28 | Insulet Corporation | $368 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-28 | Insulet Corporation | $315 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-24 | Insulet Corporation | $1,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-24 | Insulet Corporation | $373 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-24 | SANOFI-AVENTIS U.S. LLC | $121 | Food and Beverage | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-10-24 | Insulet Corporation | $24 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-24 | Insulet Corporation | $8 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-24 | Insulet Corporation | $5 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-22 | Abbott Laboratories | $4,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE Device, Diabetes Care | 2025 | |
| 2025-10-22 | Corcept Therapeutics | $1,593 | Honoraria | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-10-22 | Corcept Therapeutics | $80 | Travel and Lodging | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-10-22 | Corcept Therapeutics | $63 | Food and Beverage | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-10-21 | Abbott Laboratories | $213 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-21 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-21 | Insulet Corporation | $40 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-18 | Abbott Laboratories | $656 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-18 | Abbott Laboratories | $554 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-18 | Abbott Laboratories | $195 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-18 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-17 | Insulet Corporation | $3,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-17 | Insulet Corporation | $93 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-17 | Insulet Corporation | $32 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-17 | Insulet Corporation | $29 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-17 | Insulet Corporation | $24 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-17 | Insulet Corporation | $22 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-17 | Insulet Corporation | $18 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-16 | Corcept Therapeutics | $3,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-10-10 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-10-08 | Insulet Corporation | $4,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-08 | Corcept Therapeutics | $3,430 | Honoraria | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-10-08 | Insulet Corporation | $2,025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-08 | Novo Nordisk Inc | $1,395 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-08 | Novo Nordisk Inc | $375 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-08 | Novo Nordisk Inc | $323 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-08 | Corcept Therapeutics | $165 | Travel and Lodging | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-10-08 | Novo Nordisk Inc | $94 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-08 | Novo Nordisk Inc | $93 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-07 | Novo Nordisk Inc | $494 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-07 | Corcept Therapeutics | $32 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-10-06 | Eli Lilly and Company | $2,200 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-03 | Bayer Healthcare Pharmaceuticals Inc. | $35 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-02 | Insulet Corporation | $4,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-02 | Eli Lilly and Company | $2,200 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-02 | Insulet Corporation | $58 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-02 | Insulet Corporation | $32 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-02 | Insulet Corporation | $20 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-10-02 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-09-27 | Corcept Therapeutics | $75 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-27 | Corcept Therapeutics | $49 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-27 | Corcept Therapeutics | $48 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-27 | Corcept Therapeutics | $26 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-27 | Corcept Therapeutics | $26 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-26 | Corcept Therapeutics | $378 | Travel and Lodging | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-26 | Corcept Therapeutics | $216 | Travel and Lodging | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-26 | Corcept Therapeutics | $125 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-26 | Abbott Laboratories | $109 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-26 | Abbott Laboratories | $48 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-26 | Abbott Laboratories | $32 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-26 | Abbott Laboratories | $31 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-26 | Abbott Laboratories | $15 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-25 | Corcept Therapeutics | $1,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Korlym Drug, Endocrinology | 2025 | |
| 2025-09-25 | Mannkind Corporation | $20 | Food and Beverage | In-kind items and services | AFREZZA Drug, DIABETES MEDICINE | 2025 | |
| 2025-09-25 | Tandem Diabetes Care, Inc. | $10 | Food and Beverage | In-kind items and services | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-09-23 | Insulet Corporation | $70 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-23 | Insulet Corporation | $3 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-22 | Abbott Laboratories | $138 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-22 | Abbott Laboratories | $35 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-22 | Abbott Laboratories | $33 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-22 | Abbott Laboratories | $18 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-22 | Abbott Laboratories | $8 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-18 | Insulet Corporation | $4,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-18 | Sequel Med Tech, LLC | $17 | Food and Beverage | In-kind items and services | TWIIST Device, AUTOMATED INSULIN DELIVERY DEVICE | 2025 | |
| 2025-09-17 | Insulet Corporation | $55 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-17 | Insulet Corporation | $20 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-14 | SANOFI-AVENTIS U.S. LLC | $3,590 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-09-14 | SANOFI-AVENTIS U.S. LLC | $288 | Travel and Lodging | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-09-14 | SANOFI-AVENTIS U.S. LLC | $112 | Travel and Lodging | Cash or cash equivalent | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-09-14 | SANOFI-AVENTIS U.S. LLC | $61 | Food and Beverage | Cash or cash equivalent | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-09-14 | SANOFI-AVENTIS U.S. LLC | $45 | Travel and Lodging | Cash or cash equivalent | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-09-13 | Insulet Corporation | $279 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-13 | Insulet Corporation | $107 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-13 | Insulet Corporation | $25 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-13 | Insulet Corporation | $17 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-13 | Insulet Corporation | $7 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-12 | Insulet Corporation | $439 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-12 | Insulet Corporation | $374 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-12 | Insulet Corporation | $289 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-12 | Insulet Corporation | $133 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-12 | Insulet Corporation | $30 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-12 | Insulet Corporation | $16 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-12 | Insulet Corporation | $16 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-11 | Insulet Corporation | $1,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-11 | Insulet Corporation | $878 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-11 | Insulet Corporation | $117 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-10 | Insulet Corporation | $96 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-05 | Insulet Corporation | $878 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-05 | Abbott Laboratories | $450 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-04 | Insulet Corporation | $27 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-04 | Insulet Corporation | $27 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-03 | Insulet Corporation | $195 | Travel and Lodging | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-03 | Insulet Corporation | $129 | Food and Beverage | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-08-30 | Abbott Laboratories | $374 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-08-30 | Abbott Laboratories | $69 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-08-29 | Abbott Laboratories | $592 | Travel and Lodging | In-kind items and services | AFINION 2 Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $236 | Travel and Lodging | In-kind items and services | ALERE CHOLESTECH LDX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $174 | Travel and Lodging | In-kind items and services | ALERE CHOLESTECH LDX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Abbott Laboratories | $38 | Travel and Lodging | In-kind items and services | ALERE CHOLESTECH LDX Device, Rapid Diagnostics | 2025 | |
| 2025-08-29 | Bayer Healthcare Pharmaceuticals Inc. | $31 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-28 | Insulet Corporation | $878 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-08-28 | Insulet Corporation | $878 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-08-28 | Eli Lilly and Company | $825 | Consulting Fee | Cash or cash equivalent | 2025 |
The latest 200 records of 2,946.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-03-18 | Abbott Laboratories | Diabetes and Obesity Care | $269 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-02-14 | Abbott Laboratories | Diabetes and Obesity Care | $89 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-02-05 | Abbott Laboratories | Diabetes and Obesity Care | $1,140 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-02-05 | Abbott Laboratories | Diabetes and Obesity Care | $2,416 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-01-30 | Abbott Laboratories | Diabetes and Obesity Care | $12 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-01-30 | Abbott Laboratories | Diabetes and Obesity Care | $427 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-01-30 | Abbott Laboratories | Diabetes and Obesity Care | $35 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-01-30 | Abbott Laboratories | Diabetes and Obesity Care | $18 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-01-30 | Abbott Laboratories | Diabetes and Obesity Care | $90 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2025-01-30 | Abbott Laboratories | Diabetes and Obesity Care | $20 | ISM2512032A-Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREM | 2025 |
| 2023-04-17 | Abbott Laboratories | Diabetes and Obesity Care | $2,250 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes: Interve | 2023 |
| 2023-01-17 | Abbott Laboratories | Diabetes and Obesity Care | $750 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes: Interve | 2023 |
| 2022-10-28 | Abbott Laboratories | Diabetes and Obesity Care | $2,101 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes: Interve | 2022 |
| 2022-06-20 | Abbott Laboratories | Diabetes and Obesity Care | $5,027 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes: Interve | 2022 |
| 2021-09-27 | Abbott Laboratories | Diabetes and Obesity Care | $174 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-09-27 | Abbott Laboratories | THE DOCS | $180 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-09-27 | Abbott Laboratories | Diabetes and Obesity Care | $216 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-09-13 | Abbott Laboratories | Diabetes and Obesity Care | $3 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-09-13 | Abbott Laboratories | Diabetes and Obesity Care | $208 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-08-27 | Abbott Laboratories | THE DOCS | $270 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-08-27 | Abbott Laboratories | THE DOCS | $130 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-08-27 | Abbott Laboratories | THE DOCS | $139 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-08-04 | Abbott Laboratories | THE DOCS | $208 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-08-04 | Abbott Laboratories | THE DOCS | $217 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-07-30 | Abbott Laboratories | THE DOCS | $54 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-07-30 | Abbott Laboratories | THE DOCS | $35 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-07-30 | Abbott Laboratories | THE DOCS | $18 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-07-30 | Abbott Laboratories | THE DOCS | $12 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-07-30 | Abbott Laboratories | THE DOCS | $12 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-07-30 | Abbott Laboratories | THE DOCS | $128 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-07-30 | Abbott Laboratories | THE DOCS | $405 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-07-12 | Abbott Laboratories | Diabetes and Obesity Care | $208 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-06-03 | Abbott Laboratories | Diabetes and Obesity Care | $4 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-06-02 | Abbott Laboratories | Diabetes and Obesity Care | $417 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-06-02 | Abbott Laboratories | Diabetes and Obesity Care | $216 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-05-04 | Abbott Laboratories | Diabetes and Obesity Care | $174 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-05-04 | Abbott Laboratories | Diabetes and Obesity Care | $12 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-04-26 | Abbott Laboratories | Diabetes and Obesity Care | $26,250 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-04-13 | Abbott Laboratories | Diabetes and Obesity Care | $174 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-04-13 | Abbott Laboratories | Diabetes and Obesity Care | $208 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-04-09 | Abbott Laboratories | Diabetes and Obesity Care | $128 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-03-22 | Abbott Laboratories | Diabetes and Obesity Care | $2 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-03-22 | Abbott Laboratories | Diabetes and Obesity Care | $9 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-03-22 | Abbott Laboratories | Diabetes and Obesity Care | $21 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-03-22 | Abbott Laboratories | Diabetes and Obesity Care | $7 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-03-15 | Abbott Laboratories | Diabetes and Obesity Care | $436 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
| 2021-03-15 | Abbott Laboratories | Diabetes and Obesity Care | $213 | Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Bend, OR, county Deschutes County, OR, state Oregon; placed by its city name.
| Measure | Place (city or town) Bend, OR | County Deschutes County, OR | State Oregon |
|---|---|---|---|
| Population B01003 | 103,390 | 206,334 | 4,254,293 |
| Population, 2020 census P1 | 99,178 | 198,253 | 4,237,256 |
| Median age B01002 | 40.9 | 42.9 | 40.4 |
| Under 18 B01001 | 19.3% | 18.9% | 19.9% |
| 65 and over B01001 | 18.1% | 21.3% | 19.1% |
| Households B11001 | 44,436 | 84,933 | 1,718,422 |
| Foreign born B05002 | 4.8% | 4.9% | 9.8% |
| Median household income B19013 | $96,394 | $92,758 | $83,011 |
| Median family income B19113 | $116,302 | $110,845 | $102,281 |
| Per capita income B19301 | $58,652 | $53,083 | $45,612 |
| Poverty rate B17001 | 8.8% | 8.8% | 11.9% |
| Unemployment rate B23025 | 3.7% | 4.4% | 5.4% |
| Civilian labor force B23025 | 58,482 | 109,166 | 2,183,462 |
| Mean commute (minutes) B08013 | 16.3 | 19.6 | 23.0 |
| Bachelor's degree or higher B15003 | 52.9% | 45.0% | 36.8% |
| Housing units B25001 | 47,957 | 99,297 | 1,857,992 |
| Owner-occupied B25003 | 61.7% | 70.0% | 63.3% |
| Renters B25003 | 38.3% | 30.0% | 36.7% |
| Median home value B25077 | $718,400 | $650,900 | $477,600 |
| Median gross rent B25064 | $1,883 | $1,787 | $1,525 |
| White, not Hispanic B03002 | 82.6% | 83.5% | 71.4% |
| Black B03002 | 0.3% | 0.3% | 1.8% |
| Hispanic or Latino B03002 | 9.2% | 9.2% | 14.7% |
| Asian B03002 | 1.1% | 1.0% | 4.4% |
| American Indian and Alaska Native B03002 | 0.3% | 0.4% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bend, OR.
Comments